Alivus Life Sciences Ltd.

ALIVUS Share PricePharmaceuticals & Drugs

888.65

7.2 (0.8%)

As on December 12, 2025

Exchange Scrips: BSE543322NSEALIVUSISININE03Q201024

Market Cap10,930 Cr

P/E Ratio 22.42

Dividend Yield 0.28 %

Performance

Market performance

Open888.45
High899.75
Volumes55,174
Prev888.65
Low879.5
As on2025-12-12

Historical performance

1 Year High1,251
3 Year High1,335.1
5 Year High1,335.1
1 Year Low847.2
3 Year Low370
5 Year Low370

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
10,930
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
22.42
Dividend Yield
Dividend Yield
0.28 %

Investment Returns

1 Year
-14.3%
3 Years
100.7%
5 Years
N/A
10 Years
N/A

Technicals

IndicatorsValueSignal
5-DMA880.59Bullish
10-DMA882.37Bullish
20-DMA895.09Bearish
50-DMA909.7Bearish
100-DMA940.09Bearish
200-DMA990.38Bearish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters11111
Foreign Investors---------------
Domestic Investors11111
Public Investors135642138499141976146839143959
Government---------------

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 22.42.
  • 3Y Stock Price CAGR of the stock is 26.2.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹7172 Million.
  • The company generated revenue of ₹23869 Million in the previous financial year.

Alivus Life Sciences Ltd.

888.657.2   (0.8%)

Investment Amount: ₹ 1000000
Current Value: ₹ 872808.5
No. of Shares: 982 (Approx)
Performance:-12.7%
P/L: ₹-127191.5

Top Gainers

SymbolChange%
MAHAPEXLTD95.24(20%)
VIPULLTD10.24(20%)
TVVISION7.77(20%)
TARIL280.2(17%)
WALCHANNAG175.53(14%)

Top Losers

SymbolChange%
REFEX254.9(-20%)
VLSFINANCE299.45(-10%)
BALAXI30.06(-9%)
VLEGOV21.01(-9%)
KSR17.33(-9%)
ASMS12.2(-8%)
VINNY1.28(-7%)
RAJSREESUG37.79(-6%)

Peer Comparison

Venus Remedies Ltd.

53.5%

825.4

1 Month Performance

Nectar Lifesciences Ltd.

48.7%

21.04

1 Month Performance

SMS Pharmaceuticals Ltd.

11.4%

320.7

1 Month Performance

Natco Pharma Ltd.

10.1%

905.65

1 Month Performance

Haleos Labs Ltd.

9.8%

1386.8

1 Month Performance

Ipca Laboratories Ltd.

9.3%

1465.9

1 Month Performance

Zota Health Care Ltd.

9%

1670.2

1 Month Performance

Emcure Pharmaceuticals Ltd.

7.6%

1438.6

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month